F
FDA
Guest
On November 8-9, 2022, the U.S. Food and Drug Administration (FDA) and the International Myeloma Society (IMS) will host a joint symposium, to provide a forum for open discussion among academia, industry, and regulatory agencies about clinical drug development in multiple myeloma. The event will be held in person and online.
Baca selengkapnya di : http://www.fda.gov...
Baca selengkapnya di : http://www.fda.gov...